Taysha Gene Therapies Inc reports results for the quarter ended in June - Earnings Summary

Taysha Gene Therapies

11/08/2022 14:33

* Taysha Gene Therapies Inc  TSHA.OQ  reported a quarterly
adjusted loss of 84 cents​​ per share for the quarter ended in
June. The mean expectation of fifteen analysts for the quarter
was for a loss of 100 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Taysha Gene Therapies Inc's reported EPS for the quarter
was a
loss of 84 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Taysha Gene Therapies Inc shares had risen by 31.2% this
quarter and lost 58.1% so far this year.
    * The company reported a quarterly loss of $33.87 million.
    * Wall Street's median 12-month price target for Taysha Gene
Therapies Inc is $24.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 01:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -1.00          -0.84          Beat
 Mar. 31 2022      -1.07          -1.31          Missed
 Dec. 31 2021      -1.25          -1.32          Missed
 Sep. 30 2021      -1.08          -1.35          Missed